Is tepotinib included in domestic medical insurance? How much does a box cost?

Tepotinib was officially launched in China in 2021 for the treatment of metastatic non-small cell lung cancer (NSCLC) carrying exon 14 skipping mutations of MET. Although this drug provides patients with a new treatment option, so far, tepotinib has not been included in China's basic medical insurance list. This means the patient is responsible for the entire cost of the medication.

In China, the price of tepotinib is relatively high, about more than 30,000 yuan per box. The high cost is a heavy financial burden for many patients and their families, limiting the wide clinical application of this drug. When purchasing tepotinib, patients need to go to the local hospital pharmacy to inquire about the specific price and availability.

In comparison, the price of generic drugs abroad, especially in Laos, is much lower. The price of Tepotinib generic drugs produced in Laos is about more than 9,000 yuan per box, and the drug ingredients are basically the same as the domestic original drugs. This allows some patients with limited financial conditions to choose to purchase generic drugs to reduce financial pressure and obtain the treatment they need.

The high price of tepotinib and the fact that it is not included in medical insurance make its popularization facing certain challenges. For patients who urgently need such targeted treatments, the high cost of the drugs may force them to look for other economically viable treatments, including purchasing foreign generics or relying on charity assistance programs.

In the long term, whether tepotinib can be included in medical insurance will have an important impact on its clinical application. Inclusion in medical insurance can not only reduce the financial burden on patients, but also promote the popularization and widespread application of drugs, and improve the accessibility and fairness of treatment. The government and medical institutions should actively promote the inclusion of innovative drugs such as tepotinib in the medical insurance catalog and explore multiple payment methods to ensure that more patients can afford and use these advanced treatments.

While waiting for medical insurance coverage, patients and families should communicate closely with their doctors to understand all possible treatment options and resources, including clinical trials, charitable assistance, and international drug purchase channels, to obtain the best treatment effect and quality of life.